David Crispino Volpe, Chief Financial Officer at AdvanSource Biomaterials Corp (ASNB), bought 5,000 shares at $0.03 ($150) on 2012-11-30, disclosed to the SEC on 2012-12-04.
Open-market purchase of $150 ASNB by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| ASNB | BUY | 2012-12-10 | $300 | — | Filing → |
| ASNB | BUY | 2012-12-03 | $200 | — | Filing → |
| ASNB | BUY | 2012-11-21 | $1K | — | Filing → |